1. Huang, Yangjin, Xu, Jun, Xie, Chunming, Zeng, Yuan, Yu, Fujun. 2023. A Novel Gene Pair CSTF2/DPE2A Impacts Prognosis and Cell Cycle of Hepatocellular Carcinoma. In Journal of hepatocellular carcinoma, 10, 1639-1657. doi:10.2147/JHC.S413935. https://pubmed.ncbi.nlm.nih.gov/37791068/
2. Zheng, Yanfen, Li, Xingyang, Deng, Shuang, Zhang, Jialiang, Zuo, Zhixiang. 2023. CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. In Nature communications, 14, 6334. doi:10.1038/s41467-023-41861-y. https://pubmed.ncbi.nlm.nih.gov/37816727/
3. Wang, Jinyu, Li, Jing, Xie, Wentao, Lu, Mengji, Zhang, Jiming. 2024. The host gene CSTF2 regulates HBV replication via HBV PRE-induced nuclear export. In Acta biochimica et biophysica Sinica, , . doi:10.3724/abbs.2024216. https://pubmed.ncbi.nlm.nih.gov/39722572/
4. Grozdanov, Petar N, Masoumzadeh, Elahe, Kalscheuer, Vera M, Latham, Michael P, MacDonald, Clinton C. . A missense mutation in the CSTF2 gene that impairs the function of the RNA recognition motif and causes defects in 3' end processing is associated with intellectual disability in humans. In Nucleic acids research, 48, 9804-9821. doi:10.1093/nar/gkaa689. https://pubmed.ncbi.nlm.nih.gov/32816001/
5. Xu, Yang, Yuan, Fanen, Sun, Qian, Liu, Baohui, Chen, Qianxue. 2022. The RNA-binding protein CSTF2 regulates BAD to inhibit apoptosis in glioblastoma. In International journal of biological macromolecules, 226, 915-926. doi:10.1016/j.ijbiomac.2022.12.044. https://pubmed.ncbi.nlm.nih.gov/36521710/
6. Zhang, Qiangnu, Zhang, Yusen, Fu, Chuli, Yan, Guang-Rong, Liu, Liping. . CSTF2 Supports Hypoxia Tolerance in Hepatocellular Carcinoma by Enabling m6A Modification Evasion of PGK1 to Enhance Glycolysis. In Cancer research, 85, 515-534. doi:10.1158/0008-5472.CAN-24-2283. https://pubmed.ncbi.nlm.nih.gov/39514400/
7. Tan, Yuqin, Zheng, Tong, Zhang, Rui, Chen, Min, Na, Ning. 2022. Alternative polyadenylation writer CSTF2 forms a positive loop with FGF2 to promote tubular epithelial-mesenchymal transition and renal fibrosis. In Biochimica et biophysica acta. Molecular basis of disease, 1868, 166541. doi:10.1016/j.bbadis.2022.166541. https://pubmed.ncbi.nlm.nih.gov/36113752/
8. Köferle, Anna, Schlattl, Andreas, Hörmann, Alexandra, Mair, Barbara, Neumüller, Ralph A. . Interrogation of cancer gene dependencies reveals paralog interactions of autosome and sex chromosome-encoded genes. In Cell reports, 39, 110636. doi:10.1016/j.celrep.2022.110636. https://pubmed.ncbi.nlm.nih.gov/35417719/
9. Zhang, Wang, Wan, Yipeng, Zhang, Yue, Liu, Qi, Zhu, Xuan. 2022. CSTF2 Acts as a Prognostic Marker Correlated with Immune Infiltration in Hepatocellular Carcinoma. In Cancer management and research, 14, 2691-2709. doi:10.2147/CMAR.S359545. https://pubmed.ncbi.nlm.nih.gov/36117731/
10. Chen, Zhimin, Hao, Weijie, Tang, Jingzhi, Gao, Wei-Qiang, Xu, Huiming. 2022. CSTF2 Promotes Hepatocarcinogenesis and Hepatocellular Carcinoma Progression via Aerobic Glycolysis. In Frontiers in oncology, 12, 897804. doi:10.3389/fonc.2022.897804. https://pubmed.ncbi.nlm.nih.gov/35875122/